Medically reviewed by Dr. Diala Alatassi, MD — Double Board-Certified in Internal Medicine and Obesity Medicine
For years, the biggest question we heard from patients across Chicago and the western suburbs — from the Loop to Naperville to Oak Brook — was some version of: “Is there a pill version of Wegovy? I just can’t do injections.” As of January 2026, the answer is finally yes. The FDA approved the Wegovy® pill (oral semaglutide) in December 2025, and it’s now available at pharmacies throughout Chicagoland — with a physician evaluation you can complete from home anywhere in Illinois through TeleSlimClinic.com (https://teleslimclinic.com).
What Is the Wegovy Pill?
The Wegovy® pill is a once-daily oral tablet containing semaglutide — the same active ingredient as the well-known weekly Wegovy® injection and Ozempic®. On December 22, 2025, the FDA approved it as the first oral GLP-1 receptor agonist for chronic weight management, used alongside a reduced-calorie diet and increased physical activity, in adults with obesity or adults with overweight who have at least one weight-related medical condition. It is also approved to reduce the risk of major adverse cardiovascular events in certain adults with established cardiovascular disease.
Like all GLP-1 medications, oral semaglutide works by mimicking a hormone your body already produces — one that helps regulate appetite and fullness. Many patients find they feel satisfied sooner, stay full longer, and think about food less often, which may make it easier to sustain the eating changes that drive long-term weight loss.
Source: Novo Nordisk company announcement, December 22, 2025; Wegovy Prescribing Information.
How Well Does It Work? The OASIS 4 Data
In the OASIS 4 phase 3 trial (307 adults with obesity, or overweight with at least one weight-related condition, without diabetes), participants who adhered to once-daily oral semaglutide 25 mg lost an average of 16.6% of their body weight over 64 weeks, compared with 2.7% on placebo. Roughly one in three adherent participants lost 20% or more. In the broader treatment-policy analysis (including those who didn’t fully adhere), average weight loss was 13.6% versus 2.2% with placebo.
Two things matter here for Chicago patients considering treatment. First, that result is similar to the weekly Wegovy injection — this is not a “weaker” version of the medication. Second, the word adherent is doing real work: the pill only performs like the injection when it’s taken correctly and consistently, every day. Individual results vary, and no outcome can be guaranteed.
Source: OASIS 4, published in the New England Journal of Medicine; Novo Nordisk announcement, Dec. 22, 2025.
How the Wegovy Pill Is Taken (And Why the Routine Matters)
Per FDA-approved labeling, the Wegovy pill has a specific morning routine, because only a small fraction of oral semaglutide is absorbed. You take one tablet first thing in the morning on an empty stomach, with no more than 4 ounces of plain water. You swallow it whole — no splitting, crushing, or chewing — and then wait at least 30 minutes before eating, drinking anything else, or taking other oral medications.
Tablets come in 1.5 mg, 4 mg, 9 mg, and 25 mg strengths. Per the label, treatment starts at the lowest dose and is increased roughly every 30 days as tolerated under physician supervision, with the full treatment effect typically seen at the 25 mg maintenance dose. Your physician may hold a dose longer if needed for tolerability — this is one of the reasons ongoing medical supervision matters, and it’s exactly what our follow-up visits are designed for.
An honest note from our clinical team: if a 30-minute wait before your morning coffee, breakfast, or other medications sounds unworkable for your life, tell your physician. A weekly injection — or a different oral option — may realistically fit you better. The best medication is the one you can actually take consistently.
Wegovy Pill vs. Wegovy Injection: Which May Be Right for You?
Both contain semaglutide and produced broadly similar weight loss in trials. The differences are practical. The pill is once daily, needle-free, requires no refrigeration, and demands a strict empty-stomach morning routine. The injection is once weekly, has no food-timing rules, and is the better-studied formulation with a longer real-world track record, but involves a needle and refrigerated storage. Patients can also switch between forms with physician guidance — for example, starting on the pill and moving to the injection later, or vice versa.
At your telehealth visit, our board-certified obesity medicine physicians review your health history, medications, routine, and preferences to recommend the option that fits — and to determine whether semaglutide is appropriate for you at all.
Safety and Side Effects
The most common side effects of oral semaglutide in trials were gastrointestinal — nausea, vomiting, and diarrhea — most often mild to moderate, most noticeable when starting or increasing a dose, and often improving over time. Gradual dose escalation under supervision is designed to help your body adjust.
The Wegovy pill carries the same boxed warning as other semaglutide products regarding thyroid C-cell tumors observed in rodents; it should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome. It is also not appropriate during pregnancy, and it should not be combined with other semaglutide or GLP-1 products. This is not a complete list — a full medical evaluation is required before prescribing, which is exactly what your TeleSlim consultation provides.
Source: Wegovy Prescribing Information, Novo Nordisk.
What Does the Wegovy Pill Cost in Chicago?
Wegovy pill pricing through the manufacturer’s self-pay programs has been publicized at approximately $149 per month for starter doses and up to approximately $299 per month for the highest doses — generally lower than typical self-pay pricing for injectable GLP-1s. Pricing and savings programs change frequently, so we review current options, including manufacturer direct-pharmacy pricing, at your visit.
As a cash-pay practice, TeleSlim keeps its own fees transparent and flat — no insurance hassles, no surprise bills. Your consultation includes a full evaluation, a prescription sent to your local pharmacy when medically appropriate, and follow-up care.
How Chicago Patients Can Get Started
Getting evaluated for the Wegovy pill through TeleSlimClinic.com (https://teleslimclinic.com) is simple: book a telehealth consultation with a board-certified obesity medicine physician, complete your visit by video from anywhere in Illinois — Chicago, the suburbs, or downstate — and if oral semaglutide is medically appropriate for you, your prescription is sent to a pharmacy near you, whether that’s in Lincoln Park, Naperville, or anywhere in between.
Ready to find out if the Wegovy pill may be right for you? Book your free consultation here.
Frequently Asked Questions
Q: Is there really a pill version of Wegovy?
A: Yes. The FDA approved the Wegovy pill (once-daily oral semaglutide) on December 22, 2025, and it became available at U.S. pharmacies in January 2026. It is the first oral GLP-1 medication approved for chronic weight management.
Q: Does the Wegovy pill work as well as the injection?
A: In clinical trials, adults who adhered to the Wegovy pill lost an average of 16.6% of body weight over 64 weeks — similar to results seen with the weekly injection. Consistency and correct administration are essential, and individual results vary.
Q: How do I take the Wegovy pill?
A: Per FDA labeling, it’s taken once daily, first thing in the morning on an empty stomach with up to 4 ounces of plain water, followed by a 30-minute wait before eating, drinking, or taking other oral medications.
Q: Is the Wegovy pill the same as Rybelsus?
A: Both contain oral semaglutide, but they are approved for different uses at different doses. Rybelsus is approved for type 2 diabetes; the Wegovy pill is approved for chronic weight management at doses up to 25 mg.
Q: Can I get the Wegovy pill through telemedicine in Illinois?
A: Yes. TeleSlim’s board-certified obesity medicine physicians evaluate patients by video anywhere in Illinois and, when medically appropriate, send prescriptions to a pharmacy near you.
Q: How much does the Wegovy pill cost without insurance?
A: Manufacturer self-pay pricing has been publicized at roughly $149–$299 per month depending on dose, though pricing changes; we review current costs and savings options at your visit.
Take the first step today. Book your free consultation here.
This article is for educational purposes and is not medical advice. Wegovy® is a prescription medication that is not appropriate for everyone; a licensed physician must evaluate whether treatment is right for you. Wegovy® is a registered trademark of Novo Nordisk A/S. TeleSlim Clinic is not affiliated with Novo Nordisk.